Resources

Publications

Development of an end-to-end Quantitative Model-Informed Drug Development (MIDD) ECOSYSTEM
Using Read-Across to build Physiologically-Based Kinetic models: Part 2. Case studies for atenolol and flumioxazin
Using read-across to build physiologically-based kinetic models: Part 1. Development of a KNIME workflow to assist analogue selection for PBK modelling
Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment
Studying metabolism with multiorgan chips: new tools for diseasemodelling, pharmacokinetics and pharmacodynamics
Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans
Local depletion of large molecule drugs due to target binding in tissue interstitial space
Quantitative adverse outcome pathway (qAOP) models for toxicityprediction
Towards Predictions of Clinical Trial Outcomes: Combining PBPK and QSP within a Translational Diabetes PB-QSP Disease Platform
See all publications 

News

We are ready for PAGE 26… are you?

26. March 2026|

At the upcoming PAGE - Population Approach Group Europe Meeting, ESQlabs will offer 𝐅𝐎𝐔𝐑 𝐡𝐚𝐧𝐝𝐬-𝐨𝐧 𝐰𝐨𝐫𝐤𝐬𝐡𝐨𝐩𝐬 designed to help you build and expand your PBPK and QSP modeling skills. [...]

ESQlabs as Gold Sponsor at QSP Conference 26

2. February 2026|

After four years, the Quantitative Systems Pharmacology Conference is finally back, once again in the historic city center of Leiden, and we couldn’t be more excited to be part [...]